Average Co-Inventor Count = 4.95
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bend Research, Inc. (13 from 159 patents)
2. Glialogix, Inc. (5 from 5 patents)
3. Astellas Pharma Gmbh (3 from 417 patents)
4. Medivation Prostate Therapeutics, Inc. (3 from 12 patents)
5. Pfizer Corporation (2 from 4,455 patents)
6. Cymabay Therapeutics, Inc. (2 from 43 patents)
7. Other (1 from 832,843 patents)
8. Pfizer Products Inc. (47 patents)
26 patents:
1. 12502357 - Formulations of enzalutamide
2. 12447128 - Formulations of enzalutamide
3. 11839689 - Formulations of enzalutamide
4. 10398713 - Compositions and methods for the treatment of neurodegenerative and other diseases
5. 10098843 - Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
6. 9980978 - Compositions and methods for the treatment of neurodegenerative and other diseases
7. 9974798 - Compositions and methods for the treatment of neurodegenerative and other diseases
8. 9918997 - Compositions and methods for the treatment of neurodegenerative and other diseases
9. 9597339 - Compositions and methods for the treatment of neurodegenerative and other diseases
10. 9468604 - Pharmaceutical compositions of dispersions of drug and neutral polymers
11. 9457095 - Pharmaceutical compositions providing enhanced drug concentrations
12. 9241924 - Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
13. 8980321 - Pharmaceutical compositions providing enhanced drug concentrations
14. 8796341 - Pharmaceutical compositions providing enhanced drug concentrations
15. 8501231 - Pharmaceutical compositions providing enhanced drug concentrations